Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
Users online: 429  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page
Year : 1987  |  Volume : 32  |  Issue : 3  |  Page : 73-76

Betamethasone dipropionate (0.05) percent plus chinoform (3 percent) cream against betamethasone valerate (o.1 percent) plus chinoform cream (3 percent) in secondarily infected dermatoses.

Department of Dermatology & STD, Base Hosp. Delhi

Correspondence Address:
SP Chattopadhyay
Department of Dermatology & STD, Base Hosp. Delhi

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

ABSTRACT: This single blinds (blind evaluator) clinical study was carried out to compare the efficacy and safety of Betamethasone dipropionate plus chinoform (Diproform) cream and Betamethasone 17-valerale plus chinoform (Betnovate-C) cream in 140 cases of clinically secondarily infected steroid-responsive dermatoses. Both cream were safe and effective, the former being better than the latter. Treatment with Diproform cream resulted in a significantly lower relapse as compared to therapy with Betnovate-C.

[PDF Not available]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal